Market Value1,740,987,000
Total Holdings72
File Date2019-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Call
OTLK / Outlook Therapeutics, Inc.
IFRX / InflaRx N.V.
SRPT / Sarepta Therapeutics, Inc.
US62857M1053 / MyoKardia, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
BHVN / Biohaven Ltd. Call
/ Array BioPharma, Inc.
ITRM / Iterum Therapeutics plc
NKTR / Nektar Therapeutics
NERV / Minerva Neurosciences, Inc.
RUBY / Rubius Therapeutics, Inc.
KURA / Kura Oncology, Inc.
CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019
BOLD / Boundless Bio, Inc.
US28249H1041 / Eidos Therapeutics, Inc.
TWST / Twist Bioscience Corporation
RARX / Ra Pharmaceuticals, Inc.
ZGNX / Zogenix Inc
FIXX / Homology Medicines, Inc.
MYOV / Myovant Sciences Ltd
ACRS / Aclaris Therapeutics, Inc.
BBIO / BridgeBio Pharma, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
TBIO / Telesis Bio, Inc.
QURE / uniQure N.V.
PHAS / PhaseBio Pharmaceuticals Inc
RETA / Reata Pharmaceuticals Inc - Class A
NXTC / NextCure, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
US2103731061 / Constellation Pharmaceuticals Inc
AKRO / Akero Therapeutics, Inc.
ARNA / Arena Pharmaceuticals Inc
INCY / Incyte Corporation
US74257L1089 / Principia Biopharma Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
TCDA / Tricida Inc
KZR / Kezar Life Sciences, Inc.
DTIL / Precision BioSciences, Inc.
STOK / Stoke Therapeutics, Inc.
OTLK / Outlook Therapeutics, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
BPMC / Blueprint Medicines Corporation
QURE / uniQure N.V. Call
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
INSP / Inspire Medical Systems, Inc.
SAGE / Sage Therapeutics, Inc.
AVRO / AVROBIO, Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
GNFTF / Genfit S.A.
COLL / Collegium Pharmaceutical, Inc.
CRSP / CRISPR Therapeutics AG
GOSS / Gossamer Bio, Inc.
ATRA / Atara Biotherapeutics, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
TPTX / Turning Point Therapeutics Inc
SLDB / Solid Biosciences Inc.
QTNT / Quotient Ltd
HARP / Harpoon Therapeutics, Inc.
ALLK / Allakos Inc.
CCXI / ChemoCentryx Inc
ANAB / AnaptysBio, Inc.
IMVT / Immunovant, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
ARGX / argenx SE - Depositary Receipt (Common Stock)
XFOR / X4 Pharmaceuticals, Inc.
XLRN / Acceleron Pharma Inc
HRTX / Heron Therapeutics, Inc.
BCEL / Atreca, Inc.
MRTX / Mirati Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc. Call
ABEO / Abeona Therapeutics Inc.
NBIX / Neurocrine Biosciences, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
SRRK / Scholar Rock Holding Corporation
AXNX / Axonics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
BHVN / Biohaven Ltd.
RCKT / Rocket Pharmaceuticals, Inc.